Goldman Sachs Group Inc Emergent Bio Solutions Inc. Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 969,072 shares of EBS stock, worth $7.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
969,072
Previous 447,848 116.38%
Holding current value
$7.47 Million
Previous $3.74 Million 147.77%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$7.72 - $11.97 $4.02 Million - $6.24 Million
521,224 Added 116.38%
969,072 $9.26 Million
Q3 2024

Nov 14, 2024
SELL
$5.72 - $14.77 $933,052 - $2.41 Million
-163,121 Reduced 26.7%
447,848 $3.74 Million
Q2 2024

Aug 13, 2024
BUY
$1.86 - $6.98 $591,509 - $2.22 Million
318,016 Added 108.56%
610,969 $4.17 Million
Q1 2024

May 15, 2024
SELL
$1.5 - $3.41 $688,401 - $1.56 Million
-458,934 Reduced 61.04%
292,953 $741,000
Q4 2023

Feb 13, 2024
BUY
$1.82 - $3.16 $169,807 - $294,831
93,301 Added 14.17%
751,887 $1.8 Million
Q3 2023

May 14, 2024
SELL
$3.17 - $7.91 $295,764 - $738,010
-93,301 Reduced 12.41%
658,586 $2.24 Million
Q3 2023

Nov 14, 2023
SELL
$3.17 - $7.91 $37,608 - $93,844
-11,864 Reduced 1.77%
658,586 $2.24 Million
Q2 2023

May 14, 2024
SELL
$7.35 - $13.21 $1.69 Million - $3.04 Million
-230,095 Reduced 25.55%
670,450 $4.93 Million
Q2 2023

Aug 14, 2023
SELL
$7.35 - $13.21 $1.69 Million - $3.04 Million
-230,095 Reduced 25.55%
670,450 $4.93 Million
Q1 2023

May 14, 2024
BUY
$7.79 - $16.29 $941,811 - $1.97 Million
120,900 Added 15.51%
900,545 $9.33 Million
Q1 2023

May 11, 2023
BUY
$7.79 - $16.29 $941,811 - $1.97 Million
120,900 Added 15.51%
900,545 $9.33 Million
Q4 2022

May 14, 2024
BUY
$11.0 - $21.45 $3.53 Million - $6.88 Million
320,923 Added 69.96%
779,645 $9.21 Million
Q4 2022

Feb 13, 2023
BUY
$11.0 - $21.45 $3.53 Million - $6.88 Million
320,923 Added 69.96%
779,645 $9.21 Million
Q3 2022

May 14, 2024
BUY
$20.09 - $35.8 $7,774 - $13,854
387 Added 0.08%
458,722 $9.63 Million
Q3 2022

Nov 10, 2022
BUY
$20.09 - $35.8 $7,774 - $13,854
387 Added 0.08%
458,722 $9.63 Million
Q2 2022

May 14, 2024
SELL
$27.42 - $43.63 $8.05 Million - $12.8 Million
-293,552 Reduced 39.04%
458,335 $14.2 Million
Q2 2022

Aug 15, 2022
BUY
$27.42 - $43.63 $2.99 Million - $4.76 Million
109,018 Added 31.21%
458,335 $14.2 Million
Q1 2022

May 16, 2022
BUY
$36.48 - $52.22 $1.23 Million - $1.76 Million
33,632 Added 10.65%
349,317 $14.3 Million
Q4 2021

Feb 14, 2022
SELL
$33.11 - $55.01 $13 Million - $21.6 Million
-391,936 Reduced 55.39%
315,685 $13.7 Million
Q3 2021

Nov 10, 2021
BUY
$50.07 - $66.05 $35.4 Million - $46.7 Million
707,621 New
707,621 $35.4 Million

Others Institutions Holding EBS

# of Institutions
172
Shares Held
36.8M
Call Options Held
336K
Put Options Held
203K
View Full List

About Emergent BioSolutions Inc.

EBS Quotes by TradingView
  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $384M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email